Otenabant
Encyclopedia
Otenabant is a drug which acts as a potent and highly selective CB1 antagonist. It was developed by Pfizer
for the treatment of obesity
, but development for this application has been discontinued following the problems seen during clinical use of the similar drug rimonabant
.
Pfizer
Pfizer, Inc. is an American multinational pharmaceutical corporation. The company is based in New York City, New York with its research headquarters in Groton, Connecticut, United States...
for the treatment of obesity
Obesity
Obesity is a medical condition in which excess body fat has accumulated to the extent that it may have an adverse effect on health, leading to reduced life expectancy and/or increased health problems...
, but development for this application has been discontinued following the problems seen during clinical use of the similar drug rimonabant
Rimonabant
Rimonabant is an anorectic antiobesity drug that has been withdrawn from the market. It is an inverse agonist for the cannabinoid receptor CB1...
.